Biotech company Unnatural Products (UNP) announced the appointment of Simon Bailey, Ph.D., as its new Chief Operating Officer and President of R&D. Dr. Bailey brings over 25 years of experience in drug discovery and development to lead UNP’s growth in macrocyclic therapeutics, a promising new area of drug development.